Tailor-made treatment combined with proton beam therapy for children with genitourinary/pelvic rhabdomyosarcoma.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 25949226)

Published in Rep Pract Oncol Radiother on January 09, 2015

Authors

Hiroko Fukushima1, Takashi Fukushima1, Aiko Sakai2, Ryoko Suzuki2, Chie Kobayashi1, Yoshiko Oshiro3, Masashi Mizumoto3, Noriko Hoshino4, Chikashi Gotoh4, Yasuhisa Urita4, Hiroaki Komuro4, Michio Kaneko4, Noritoshi Sekido5, Kouji Masumoto4, Hideyuki Sakurai3, Ryo Sumazaki1

Author Affiliations

1: Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan ; Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan.
2: Department of Pediatrics, University of Tsukuba Hospital, Tsukuba, Japan.
3: Department of Radiation Oncology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
4: Department of Pediatric Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
5: Department of Urology, Toho University Medical Center Ohashi Hospital, Meguro-Ku, Tokyo, Japan ; Department of Urology, University of Tsukuba Hospital, Tsukuba, Japan.

Articles cited by this

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol (2001) 5.46

Rhabdomyosarcoma: new windows of opportunity. Oncologist (2005) 1.64

Management of radiation-induced vesicovaginal fistula. Eur Urol (2008) 1.54

Proton beam and prostate cancer: An evolving debate. Rep Pract Oncol Radiother (2013) 1.48

A modified surgical technique for treatment of radiation-induced vesicovaginal fistulas. Urology (2012) 1.46

Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol (2010) 1.43

An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol (2012) 1.28

Rhabdomyosarcoma in children: a SEER population based study. J Surg Res (2011) 1.13

Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.12

Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee. Int J Cancer (2011) 1.06

Prostate embryonal rhabdomyosarcoma in adults: Case report and review of literature. Rep Pract Oncol Radiother (2013) 0.96

The irradiation tolerance dose of the proximal vagina. Radiother Oncol (2003) 0.93

Clinical results of proton beam therapy for advanced neuroblastoma. Radiat Oncol (2013) 0.85

Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96. Pediatr Blood Cancer (2010) 0.85

Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas. Radiat Oncol (2013) 0.84

Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee. Eur J Cancer (2011) 0.80

Long-term results in childhood rhabdomyosarcoma: a report from the Italian Cooperative Study RMS 79. Pediatr Blood Cancer (2011) 0.80

Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcoma. J Pediatr Surg (1997) 0.78